Nrf2 deficiency impairs fracture healing in mice

Sebastian Lippross1, Rainer Beckmann, Nadine Streubesand

  • 1Department of Trauma Surgery, University Medical Center of Schleswig-Holstein, Campus Kiel, Kiel, Germany, Sebastian.lippross@uksh-kiel.de.

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) is crucial for bone healing. Nrf2 deficiency in mice impaired fracture healing, showing reduced callus formation and strength, highlighting Nrf2

Area of Science:

  • Biomedical Science
  • Regenerative Medicine
  • Skeletal Biology

Background:

  • Oxidative stress impacts wound healing, but its role in fracture healing is less understood.
  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of cellular antioxidant defenses.
  • Nrf2's specific role in bone regeneration requires further investigation.

Purpose of the Study:

  • To investigate the role of Nrf2 in bone fracture healing.
  • To compare fracture healing in wild-type (WT) and Nrf2-knockout (Nrf2-KO) mice.
  • To assess the impact of Nrf2 deficiency on bone healing processes and outcomes.

Main Methods:

  • Utilized a standard closed femoral shaft fracture model in WT and Nrf2-KO mice.
  • Evaluated fracture healing through histological analysis, real-time RT-PCR, micro-computed tomography (µCT), and biomechanical testing.
  • Measured gene expression of key healing markers like VEGF and osteocalcin.

Main Results:

  • Nrf2 expression was activated during the fracture healing process.
  • Nrf2-KO mice exhibited retarded bone healing and remodeling compared to WT mice.
  • Nrf2-KO mice showed significantly reduced callus formation, lower biomechanical strength, and decreased VEGF and osteocalcin expression.

Conclusions:

  • Nrf2 plays an essential role in bone regeneration and fracture healing.
  • Nrf2 deficiency leads to impaired fracture healing outcomes in mice.
  • Targeting Nrf2 pharmacologically presents a potential therapeutic strategy for enhancing fracture repair.